scholarly journals Immune Dysfunction and Cognitive Deficit in Stress and Physiological Aging. Part II: New Approaches to Cognitive Disorder Prevention and Treatment

2014 ◽  
Vol 69 (7-8) ◽  
pp. 30-37
Author(s):  
A.L. Pukhal'sky ◽  
◽  
G.V. Shmarina ◽  
V.A. Aleshkin ◽  
◽  
...  
Pharmaceutics ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 815
Author(s):  
Bárbara Costa ◽  
Nuno Vale

The pandemic of the coronavirus disease 2019 (COVID-19) represents an unprecedented challenge to identify effective drugs for prevention and treatment. While the world’s attention is focused on news of COVID-19 vaccine updates, clinical management still requires improvement. Due to the similarity of cancer-induced inflammation, immune dysfunction, and coagulopathy to COVID-19, anticancer drugs, such as Interferon, Pembrolizumab or Bicalutamide, are already being tested in clinical trials for repurposing, alone or in combination. Given the rapid pace of scientific discovery and clinical data generated by the large number of people rapidly infected, clinicians need effective medical treatments for this infection.


2020 ◽  
Vol 60 (6) ◽  
pp. e173-e178 ◽  
Author(s):  
Aaron Salwan ◽  
Nicholas E. Hagemeier ◽  
Fred Tudiver ◽  
KariLynn Dowling-McClay ◽  
Kelly N. Foster ◽  
...  

2000 ◽  
Vol 36 (8) ◽  
pp. 529 ◽  
Author(s):  
Y.-Q. Xiong ◽  
M.R. Yeaman ◽  
A.S. Bayer

Author(s):  
Alexander V. Pronin ◽  
Alexander N. Narovlyansky ◽  
Alexander V. Sanin

Sign in / Sign up

Export Citation Format

Share Document